Quadrant Capital Group LLC lessened its position in Roche Holdings AG Basel ADR Common Stock (OTCMKTS:RHHBY) by 35.5% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 11,964 shares of the company’s stock after selling 6,592 shares during the period. Quadrant Capital Group LLC’s holdings in Roche Holdings AG Basel ADR Common Stock were worth $313,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Chickasaw Capital Management LLC lifted its stake in shares of Roche Holdings AG Basel ADR Common Stock by 5.0% in the second quarter. Chickasaw Capital Management LLC now owns 42,000 shares of the company’s stock valued at $1,166,000 after purchasing an additional 2,000 shares during the period. Todd Asset Management LLC lifted its stake in shares of Roche Holdings AG Basel ADR Common Stock by 2.3% in the second quarter. Todd Asset Management LLC now owns 118,900 shares of the company’s stock valued at $3,285,000 after purchasing an additional 2,700 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI lifted its stake in shares of Roche Holdings AG Basel ADR Common Stock by 2.1% in the first quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 178,850 shares of the company’s stock valued at $5,115,000 after purchasing an additional 3,650 shares during the period. Oxbow Advisors LLC lifted its stake in shares of Roche Holdings AG Basel ADR Common Stock by 3.3% in the first quarter. Oxbow Advisors LLC now owns 148,090 shares of the company’s stock valued at $4,239,000 after purchasing an additional 4,665 shares during the period. Finally, Pillar Pacific Capital Management LLC lifted its stake in shares of Roche Holdings AG Basel ADR Common Stock by 3.8% in the second quarter. Pillar Pacific Capital Management LLC now owns 154,118 shares of the company’s stock valued at $4,279,000 after purchasing an additional 5,635 shares during the period. Institutional investors own 0.58% of the company’s stock.

Shares of OTCMKTS RHHBY opened at $30.12 on Monday. The company has a quick ratio of 1.09, a current ratio of 1.42 and a debt-to-equity ratio of 0.55. Roche Holdings AG Basel ADR Common Stock has a 52 week low of $26.30 and a 52 week high of $32.42. The stock has a market capitalization of $204.67 billion, a P/E ratio of 15.45, a P/E/G ratio of 2.05 and a beta of 0.62.

Several brokerages recently commented on RHHBY. ValuEngine upgraded shares of Roche Holdings AG Basel ADR Common Stock from a “sell” rating to a “hold” rating in a research note on Monday, July 30th. Cowen reiterated a “buy” rating and issued a $34.00 price objective on shares of Roche Holdings AG Basel ADR Common Stock in a research note on Thursday, July 26th. Sanford C. Bernstein cut shares of Roche Holdings AG Basel ADR Common Stock from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 10th. Finally, Credit Suisse Group reiterated an “underperform” rating on shares of Roche Holdings AG Basel ADR Common Stock in a research note on Friday, May 25th. Six analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $33.00.

About Roche Holdings AG Basel ADR Common Stock

Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

Recommended Story: Trading Strategy Methods and Types

Institutional Ownership by Quarter for Roche Holdings AG Basel ADR Common Stock (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Holdings AG Basel ADR Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holdings AG Basel ADR Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.